US-based medical device company AcuFocus secured $65m in funding last Tuesday, consisting of $40m in equity and a $25m ‘synthetic royalty’ payment from private equity firm Cowen Healthcare Royalty Partners. Cowen led the round, investing a total of $30m. Also participating in the round were medical technology company Medtronic, eye health company Bausch & Lomb, and venture capital (VC) firms Versant Ventures, the Carlyle Group and Accuitive Medical Ventures. Prior to the latest round, AcuFocus had raised about $34.5m, with $18m of that coming from a series D round in 2007. Previous investors include Shroder Ventures, the VC division of asset management firm Shroders, as well as Pequot Ventures, which has since become VC firm FirstMark Capital, and Boston Innovative Optics. Founded in 2001, AcuFocus’ lead product is the Kamra inlay, a treatment for nearsightedness which is available in markets across Europe and other parts of the world. AcuFocus us preparing to submit Kamra to the US Food and Drug Administration in 2012 for regulatory approval.
- News & Analysis
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Deal Data
- Community & Events
Corporates see AcuFocus to a $65m round
Dec 5, 2011 • Robert Lavine
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Featured ContentFUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.
FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.NOMINATE Nominations for the GCV Powerlist 2024 are now open
Nominations for the GCV Powerlist 2024 are now openEventsWebinar: Startups and Strategics – What works and what doesn’tEventsGCV Institute: Landing the Value of Corporate VenturingTop News
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.test reg